| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 08/26/2004 | WO2004072246A2 Polymerase-based protocols for the introduction of combinatorial deletions and insertions |
| 08/26/2004 | WO2004072245A2 Polymerase-based protocols for the introductions of deletions and insertions |
| 08/26/2004 | WO2004072244A2 Polymerase-based protocols for generating chimeric oligonucleotides |
| 08/26/2004 | WO2004072243A2 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | WO2004072241A2 Compositions and methods for cleaving iap |
| 08/26/2004 | WO2004072238A2 Terminal-phosphate-labeled nucleotides with new linkers |
| 08/26/2004 | WO2004072237A2 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine |
| 08/26/2004 | WO2004072236A2 Methods and compositions for 3-d sodium dodecyl sulfate-polyacrylamide cube gel electrophoresis |
| 08/26/2004 | WO2004072234A2 Protection of nucleosides |
| 08/26/2004 | WO2004072233A2 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use |
| 08/26/2004 | WO2004072232A2 Covalent tethering of functional groups to proteins |
| 08/26/2004 | WO2004072231A2 Pathogen inactivation assay |
| 08/26/2004 | WO2004072230A2 Real-time polymerase chain reaction using large target amplicons |
| 08/26/2004 | WO2004072229A2 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/26/2004 | WO2004072228A2 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
| 08/26/2004 | WO2004072227A2 Animal testing procedure |
| 08/26/2004 | WO2004072220A2 Process of sex selection of mammal spermatozoa and method to control quality of frozen sexed semen doses |
| 08/26/2004 | WO2004050897A3 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera |
| 08/26/2004 | WO2004048530A3 Compositions and methods for the reversible capture of biomolecules |
| 08/26/2004 | WO2004046379A9 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 08/26/2004 | WO2004046318A3 Improved clonal cell lines derived from bti-tn-5b1-4 |
| 08/26/2004 | WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof |
| 08/26/2004 | WO2004044145A3 Compositions and methods for enhancing disease resistance in fish |
| 08/26/2004 | WO2004044141A8 Conjugated oligomeric compounds and their use in gene modulation |
| 08/26/2004 | WO2004033649A3 High throughput multiplex dna sequence amplifications |
| 08/26/2004 | WO2004031356A3 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 08/26/2004 | WO2004016755A3 Amplification of target nucleotide sequence without polymerase chain reaction |
| 08/26/2004 | WO2003035843A3 Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby |
| 08/26/2004 | WO2003035829A3 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 08/26/2004 | US20040168211 Regulation of quinolate phosphoribosyl transferase expression |
| 08/26/2004 | CA2515699A1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | CA2515684A1 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof |
| 08/26/2004 | CA2515677A1 Methods for monitoring drug activities in vivo |
| 08/26/2004 | CA2515216A1 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | CA2515211A1 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine |
| 08/26/2004 | CA2515040A1 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
| 08/26/2004 | CA2515039A1 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/26/2004 | CA2514564A1 Covalent tethering of functional groups to proteins |
| 08/26/2004 | CA2513668A1 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1448799A2 Compositions and methods of selective nucleic acid isolation |
| 08/25/2004 | EP1448766A2 Coisogenic eukaryotic cell collections |
| 08/25/2004 | EP0922092B1 Method of attenuating viruses |
| 08/25/2004 | CN1163509C RET ligand (RetL) for stimulating neural and renal growth |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/19/2004 | WO2004070019A2 Membrane active polymers |
| 08/19/2004 | WO2004070015A2 Nematode pan and zp receptor-like sequences |
| 08/19/2004 | WO2004070013A2 Use of islet 1 as a marker for isolating or generating stem cells |
| 08/19/2004 | WO2004070012A2 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | WO2004070009A2 Targeted multivalent macromolecules |
| 08/19/2004 | WO2004070008A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 08/19/2004 | WO2004070006A2 Nucleic acid antigens embedded in thermoplastic |
| 08/19/2004 | WO2004070004A2 Rat receptor tyrosine kinase, kdr |
| 08/19/2004 | WO2004070003A2 Methods for selecting and screening for trasformants |
| 08/19/2004 | WO2004070002A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/19/2004 | WO2004070001A2 Assay and compositions for detection of bacillus anthracis nucleic acid |
| 08/19/2004 | WO2004070000A2 Htlv-i-cell binding and inhibition |
| 08/19/2004 | WO2004069999A2 Screening method |
| 08/19/2004 | WO2004069992A2 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | WO2004069991A2 Oligomeric compounds for the modulation of survivin expression |
| 08/19/2004 | WO2004069182A2 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | WO2004048536A3 Rhebs as modifiers of the rb pathway and methods of use |
| 08/19/2004 | WO2004003136A3 Methods of detecting sequence differences |
| 08/19/2004 | WO2003083086A3 High level expression of immunogenic proteins in the plastids of higher plants |
| 08/19/2004 | WO2003074658A3 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data |
| 08/19/2004 | WO2003006625A8 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 08/19/2004 | WO2003001876A8 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 08/19/2004 | US20040161419 Novel cells obtained from amnion, chorion and decidual layers; expressing markers from Thy-1, OCT-4, SOX2, SSEA3, SSEA4, TRA1-60, TRA1-81, Lefty A, FGF-4, Rex-1 and/or TDGF-1 |
| 08/19/2004 | CA2515644A1 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | CA2515623A1 Oligomeric compounds for the modulation of survivin expression |
| 08/19/2004 | CA2515000A1 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 08/19/2004 | CA2514841A1 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | CA2514838A1 Nucleic acid antigens embedded in thermoplastic |
| 08/19/2004 | CA2514810A1 Use of islet 1 as a marker for isolating or generating stem cells |
| 08/19/2004 | CA2513722A1 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | CA2512624A1 Rat receptor tyrosine kinase, kdr |
| 08/19/2004 | CA2506619A1 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/18/2004 | EP1446476A2 Endothelial cells derived from primate embryonic stem cells |
| 08/18/2004 | CN1521263A PCR method |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/17/2004 | US6777210 Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1 |
| 08/12/2004 | WO2004067731A1 New strains of bifidobacterium having the ability to produce glutamine |
| 08/12/2004 | WO2004067726A2 Isothermal reactions for the amplification of oligonucleotides |
| 08/12/2004 | WO2004067724A2 Methods of identifying and designing cell surface receptor inhibitors |
| 08/12/2004 | WO2004067720A2 Systems and methods for predicting specific genetic loci that affect phenotypic traits |
| 08/12/2004 | WO2004067715A2 Anonymous testing system and kit |
| 08/12/2004 | WO2004067714A2 Process and apparatus for microwave desorption of elements or species from carbon nanotubes |
| 08/12/2004 | WO2004067698A2 Helminth-derived antigens having capacity of providing protection against parasites |
| 08/12/2004 | WO2004046307A3 Scanning of biological samples |
| 08/12/2004 | WO2004042003A3 Cell lysis compositions, methods of use, apparatus, and kit |
| 08/12/2004 | WO2004020592A3 Retroductal salivary gland genetic vaccination |
| 08/12/2004 | WO2004003132A3 Methods and systems of biomolecular sequence matching |
| 08/12/2004 | WO2003099998A3 Gene expression profiling of adult soft tissue sarcoma |
| 08/12/2004 | US20040158055 Protection of nucleosides |
| 08/12/2004 | US20040157223 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/12/2004 | US20040157219 comprises an alkaline agent, at least one detergent, and a suspension of paramagnetic particles and an acidic solution |
| 08/12/2004 | US20040157218 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
| 08/12/2004 | CA2514934A1 Methods of identifying and designing cell surface receptor inhibitors |
| 08/12/2004 | CA2514659A1 New strains of bifidobacterium having the ability to produce glutamine |
| 08/12/2004 | CA2514180A1 Systems and methods for predicting specific genetic loci that affect phenotypic traits |